Meeder Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-268
Closed 2443
2021
Q3
$0 Sell
268
-97
-27% -$218 ﹤0.01% 2677
2021
Q2
$1K Buy
365
+6
+2% +$15 ﹤0.01% 2421
2021
Q1
$1K Buy
+359
New +$1.3K ﹤0.01% 2284
2020
Q4
Sell
-359
Closed 2289
2020
Q3
$0 Hold
359
﹤0.01% 2421
2020
Q2
$0 Hold
359
﹤0.01% 2557
2020
Q1
$0 Buy
+359
New +$375 ﹤0.01% 2581
2017
Q2
Sell
-173
Closed -$3K 1924
2017
Q1
$3K Hold
173
﹤0.01% 1289
2016
Q4
$3K Buy
+173
New +$3.55K ﹤0.01% 912

Other funds holding ASXC

Meeder Asset Management's ASXC Position: Q4 2021 in Review

Meeder Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2021, closing a stake of 268 shares.

Meeder Asset Management first reported a position in ASXC in Q4 2016 and held it in 8 quarters. The position peaked at $3K in Q1 2017. 114 funds tracked by Wall St. Rank hold ASXC as of Q4 2021.

  • Meeder Asset Management reported no remaining Asensus Surgical, Inc. position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 268 Asensus Surgical, Inc. shares in Q4 2021.
  • Meeder Asset Management first reported a position in Asensus Surgical, Inc. in Q4 2016 and held it in 8 quarters.
  • Meeder Asset Management's Asensus Surgical, Inc. position peaked at $3K in Q1 2017.
  • 114 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.